Canada markets open in 8 hours 38 minutes
  • S&P/TSX

    19,201.28
    -26.72 (-0.14%)
     
  • S&P 500

    4,127.99
    -0.81 (-0.02%)
     
  • DOW

    33,745.40
    -55.20 (-0.16%)
     
  • CAD/USD

    0.7949
    -0.0012 (-0.16%)
     
  • CRUDE OIL

    60.01
    +0.31 (+0.52%)
     
  • BTC-CAD

    76,164.26
    -21.38 (-0.03%)
     
  • CMC Crypto 200

    1,293.41
    -1.17 (-0.09%)
     
  • GOLD FUTURES

    1,728.90
    -3.80 (-0.22%)
     
  • RUSSELL 2000

    2,233.78
    -9.69 (-0.43%)
     
  • 10-Yr Bond

    1.6750
    0.0000 (0.00%)
     
  • NASDAQ futures

    13,793.25
    -15.50 (-0.11%)
     
  • VOLATILITY

    16.91
    +0.22 (+1.32%)
     
  • FTSE

    6,889.12
    -26.63 (-0.39%)
     
  • NIKKEI 225

    29,829.60
    +290.87 (+0.98%)
     
  • CAD/EUR

    0.6684
    +0.0007 (+0.10%)
     

Flexion Therapeutics to Present at the Needham 20th Annual Virtual Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
Flexion Therapeutics, Inc.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

BURLINGTON, Mass., April 08, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the Needham 20th Annual Healthcare Conference. The virtual fireside chat is scheduled to begin at 9:30 a.m. ET on Thursday, April 15, 2021.

To access the live webcast of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com.

About Flexion Therapeutics
Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The company's core values are focus, ingenuity, tenacity, transparency and fun. Please visit flexiontherapeutics.com.

Contact:

Scott Young
Vice President, Corporate Communications & Investor Relations
Flexion Therapeutics, Inc.
T: 781-305-7194
syoung@flexiontherapeutics.com